Cargando…

Thrombin Decrease in Thrombin Generation after Heparin Administration in a Homozygous Type II Heparin-Binding Site Antithrombin-Deficient Pregnant Woman

OBJECTIVES: There is a major problem in providing prophylactic treatment in antithrombin (AT)-deficient pregnant women with a homozygous mutation of the heparin-binding site and AT level of 17%. The aim of the study was to determine the effectiveness of heparin by monitoring changes in thrombin gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malíková, Ivana, Husáková, Martina, Bílková, Jana, Brzežková, Radka, Kvasnička, Tomáš
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659590/ https://www.ncbi.nlm.nih.gov/pubmed/37703851 http://dx.doi.org/10.1159/000533801

Ejemplares similares

Thrombin Generation Decrease After LMWH Administration in an Antithrombin-Deficient Pregnant Woman With a Homozygous HBS II Mutation
por: Malikova, Ivana, et al.
Publicado: (2023)

On the Specificity of Heparin/Heparan Sulfate Binding to Proteins. Anion-Binding Sites on Antithrombin and Thrombin Are Fundamentally Different
por: Mosier, Philip D., et al.
Publicado: (2012)

Treatment of Homozygous Type II Antithrombin Heparin-Binding Site Deficiency in Pregnancy
por: Fiskvik, Hilde, et al.
Publicado: (2021)

Validation of high concentrated thrombin time assay for unfractionated heparin monitoring
por: Apipongrat, Dollapak, et al.
Publicado: (2022)

Management of heparin resistance due to antithrombin deficiency in a Chinese pregnant woman: a case report
por: Zhang, Xiaoxin, et al.
Publicado: (2021)

Early Changes in the Antithrombin and Thrombin-Antithrombin Complex in Patients With Paroxysmal Atrial Fibrillation
por: Negreva, Mariya, et al.
Publicado: (2016)

Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Functional Characterization of Antithrombin Mutations by Monitoring of Thrombin Inhibition Kinetics
por: Reda, Sara, et al.
Publicado: (2021)

Effect of a Direct Thrombin Inhibitor Compared with Dalteparin and Unfractionated Heparin on Human Osteoblasts
por: Winkler, Tobias, et al.
Publicado: (2011)

Thrombin antithrombin complex and IL-18 serum levels in stroke patients
por: Piazza, Ornella, et al.
Publicado: (2010)

Recombinant dermatan sulfate is a potent activator of heparin cofactor II-dependent inhibition of thrombin
por: Tykesson, Emil, et al.
Publicado: (2019)

28 day post-operative persisted hypercoagulability after surgery for benign diseases: a prospective cohort study
por: Ulrych, Jan, et al.
Publicado: (2016)

Successful use of an antithrombin for heparin resistance with andexanet alfa
por: Honda, Jun, et al.
Publicado: (2023)

A case report of atrial fibrillation in a patient with heparin resistance associated with an antithrombin III deficiency successfully treated by radiofrequency catheter ablation using a direct thrombin inhibitor
por: Kang, Honsa, et al.
Publicado: (2019)

Effects of Heparin and Bivalirudin on Thrombin-Induced Platelet Activation: Differential Modulation of PAR Signaling Drives Divergent Prothrombotic Responses
por: Lund, Mikael, et al.
Publicado: (2021)

Dabigatran, a direct thrombin inhibitor, can be a life-saving treatment in heparin-induced thrombocytopenia
por: Mirdamadi, Ahmad
Publicado: (2013)

Overcoming heparin resistance in pregnant women with antithrombin deficiency: a case report and review of the literature
por: Tsikouras, Panagiotis, et al.
Publicado: (2018)

Apixaban therapy in a pregnant woman with heparin-induced thrombocytopenia and venous thromboembolic events caused by congenital antithrombin deficiency: A case report
por: Komori, Mayuko, et al.
Publicado: (2020)

An Antithrombin-Heparin Complex Increases the Anticoagulant Activity of Fibrin Clots
por: Smith, Lesley J., et al.
Publicado: (2008)

New Insights in Thrombin Inhibition Structure–Activity Relationships by Characterization of Octadecasaccharides from Low Molecular Weight Heparin †
por: Mourier, Pierre A. J., et al.
Publicado: (2017)

Elevated Microparticles, Thrombin-antithrombin and VEGF Levels in Colorectal Cancer Patients Undergoing Chemotherapy
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2020)

Tailoring the effect of antithrombin-targeting therapy in haemophilia A using in silico thrombin generation
por: de Laat-Kremers, Romy M. W., et al.
Publicado: (2021)

Thrombin Generation in Chinese Pregnant Women and the Effect of Insulin Use on Thrombin Generation in Patients with GDM
por: Dong, Feng, et al.
Publicado: (2019)

The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand
por: Boyle, Amanda J, et al.
Publicado: (2013)

Direct thrombin inhibitors as alternatives to heparin to preserve lung growth and function in a murine model of compensatory lung growth
por: Tsikis, Savas T., et al.
Publicado: (2022)

Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site
por: Bohdan, Nataliya, et al.
Publicado: (2016)

Thrombin generation capacity is enhanced by low antithrombin activity and depends on the activity of the related coagulation factors
por: Tsuchida, Takumi, et al.
Publicado: (2022)

Effect of plasma thrombin-antithrombin complex on ischemic stroke: a systematic review and meta-analysis
por: Song, Peipei, et al.
Publicado: (2023)

Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis
por: Kremers, Romy M. W., et al.
Publicado: (2017)

Plasma centrifugation does not influence thrombin-antithrombin and plasmin-antiplasmin levels but determines platelet microparticles count
por: Stępień, Ewa, et al.
Publicado: (2015)

Comparison of antithrombin‐dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots
por: Salta, Stella, et al.
Publicado: (2018)

Increased perihematomal neuron autophagy and plasma thrombin–antithrombin levels in patients with intracerebral hemorrhage: An observational study
por: Wu, Chenghan, et al.
Publicado: (2019)

Interactions of nebulized heparin with intravenous antithrombin for combined therapy of acute lung injury
por: Rehberg, S, et al.
Publicado: (2011)

Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods
por: Gindele, Réka, et al.
Publicado: (2021)

Comparison of antithrombin activity assays in detection of patients with heparin binding site antithrombin deficiency: systematic review and meta-analysis
por: Rojnik, Tamara, et al.
Publicado: (2023)

Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia
por: Ciurzyński, Michał, et al.
Publicado: (2011)

Atrial Fibrillation in a Patient with Heparin-induced Thrombocytopenia Successfully Treated by Radiofrequency Catheter Ablation Using a Direct Thrombin Inhibitor
por: Sakai, Togo, et al.
Publicado: (2022)

PURIFICATION OF THROMBIN
por: Milstone, H.
Publicado: (1942)

Effect of unfractionated and low molecular weight heparin on microcirculatory antithrombin effects during endotoxemia
por: Hoffmann, JN, et al.
Publicado: (2002)

Elucidating the specificity of non-heparin-based conformational activators of antithrombin for factor Xa inhibition
por: Rashid, Qudsia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0vkaflfu5b9pghn29bkjvvr4ji